In-hospital Post Partum Implant and IUD Tracking
|Principal Investigator: Jennifer Eggebroten|
|Keywords: Contraception , IUD , Family Planning , Nexplanon , Inplanon||Department: Obstetrics And Gynecology (Dept)|
|IRB Number: 00063859||Co Investigator: Jennifer Eggebroten|
|Specialty: OB/Gyn, General|
|Sub Specialties: Contraception and Family Planning|
1. Evaluate patient intent to receive and uptake of in-hospital post-partum highly effective, reversible contraception (LARC) including the Mirena, Paragard, and Nexplanon regardless of ability to pay
2. Evaluate satisfaction with with in hospital placement of Nexplanon or IUD following delivery.
3. Determine the continuation rate for long acting reversible contraceptives at 3, 6, 9, 12, and 18 months following in-hospital placement.
4. Evaluate expulsion rate and need for ultrasound to located IUDs placed immediately following delivery of the placenta on L&D.
Eligible participants will include post-partum women who request Nexplanon or IUD in the immediate post-partum period (in the hospital immediately after delivery) through a grant program providing free long-term reversible contraception to low-income women. This includes women in households making less than 300% of the federal poverty level and who do not have postpartum contraception insurance or whose coverage makes these contraceptives prohibitively expensive.
These patients will be offered in-hospital placement of the IUD or Nexplanon during their routine prenatal visits but counseled that circumstances may prevent its placement. These include lack of a trained provider, limited supply, or development of a contraindication such as chorioamnionitis or post-partum hemorrhage. We plan to invite both women who receive the IUD or Nexplanon and those who request it but are not able to obtain it in order to follow both groups' uptake and satisfaction with their chose contraception.
The majority of these patients will receive their care at the South Main Clinic or Community Health Center though we will invite other eligible patients to participate as well. Patients with emergency Medicaid will qualify for the study though patients with traditional Medicaid will not as traditional Medicaid does have a contraceptive benefit.
Participants will be excluded for the following reason:
1. They do not meet the eligibility criteria to receive the LARC grant.
2. They decline to participate in the study.